Amarin Corp Plc (AMRN)

[Biobillionair]

Yes, the FDA should provide data that refutes or agrees with Amarin. But they failed to make a full presentation.

I believe the placebo issue was probable due to not enough washout time...either diet, fibrates, ... Continued to wash out after Study began increasing baseline to end of 12 weeks.

At this point I'd vote to wait. The FDA really F'd this up with no safety presentation.

Remember new AACE guidelines do recommend Omega 3. The FDA can't change that. They should be fair and change the labeling of niacin and fibrates they don't approve Anchor.